# FLGT — Fulgent Genetics Inc · catalysts, narrative & risks

**Deep-research report — K3vl4r**  
**Symbols:** FLGT  
**Sources:** 20  
**Published:** 2026-10-31  
**Canonical:** https://app.k3vl4r.com/research/deep-research-flgt-fulgent-genetics-inc-catalysts-narrative-risks-10359

---

## Snapshot (as of 2026-10-30/31)

As of the close on October 30, 2026, FLGT traded at $20.62, down 4.89% on the day, with after-hours trading near $20.53 [[4]](https://www.marketbeat.com/stocks/NASDAQ/FLGT/), [[17]](https://finance.yahoo.com/quote/FLGT/news/). Market capitalization was ~$567.26 million, within the 52-week range of $13.46–$31.04 [[4]](https://www.marketbeat.com/stocks/NASDAQ/FLGT/). This is consistent with the on-file background data (market cap ~$567.37M) [background]. Analyst consensus is a "Hold" rating with a $27.50 price target implying roughly 33.4% upside, though coverage is thin—only 2 research reports in the past 90 days [[4]](https://www.marketbeat.com/stocks/NASDAQ/FLGT/).

## Recent catalysts (roughly Aug–Oct 2026)

---

_Preview only. The complete multi-source deep-research report — full thesis, evidence, and citations — is available at https://app.k3vl4r.com/research/deep-research-flgt-fulgent-genetics-inc-catalysts-narrative-risks-10359 (free to sign up)._